Ratio Therapeutics (Series B)

Funding Details
Awarder
Inbox
Date Award
January 17, 2024
Vertical
Pharmaceuticals
Funding URL
View Funding Page
Funding Amount:
$50,000,000

Company Info
Founders
John Babich, Ph.D., Jack Hoppin, Ph.D.
Company Description
Ratio Therapeutics is a clinical phase pharmaceutical company that develops radiopharmaceuticals for solid tumors.
Market
Oncology
Location
Boston, MA, USA
Coinvestors
Bristol Myers Squibb, Cornell Center for Technology Licensing, Duquesne Family Office, PAGS Group, Schusterman Family Interests

Links